
MetALD Conference
@metaldconf
San Diego MetALD Conference: Opportunities and Challenges in Biomarkers and Clinical Drug Development
ID: 1841907288698687488
https://www.metaldconference.org/ 03-10-2024 18:25:40
23 Tweet
45 Followers
5 Following

Ramon Bataller, MD, PHD Ramon Bataller is discussing current and emerging therapies for MetALD at the San Diego MetALD Conference! Register now to hear his insights at loom.ly/dbXQxmA.



Dr. Vijay H. Shah is teaching you how to incorporate PEth and other biomarkers in clinical trials, studies and routine clinical practice. Join him at MetALD Conference on November 14th. Register at loom.ly/dbXQxmA. Vijay Shah


Global Epidemiology of Alcohol Use and Metabolic Dysfunction in Liver Disease is being presented by Aleksander Krag at MetALD Conference! Don't miss this insightful session- Register now at loom.ly/Vr0YS88 Aleksander Krag


Juan Pablo Arab, MD, FRCPC is discussing Risk Factors for MetALD, Natural History, and Risk of Progression to Cirrhosis and HE Mortality/Transplant at MetALD Conference! Juan Pablo (JP) Arab, MD


Dr. Rohit Loomba Rohit Loomba leads the discussion on MetALD on November 14th - Register Now!





We’re proud to sponsor this year’s MetALD Conference exploring the opportunities & challenges in #clinical drug development as we continue to advance innovative therapeutics for patients with #metabolic dysfunction-associated liver diseases: bit.ly/3CboUsn

Kick starting MetALD Conference in San Diego how to diagnose metALD in clinic ? Veeral Ajmera AASLD American Gastroenterological Association (AGA) Quentin M. Anstee Aleksander Krag




Great talk Juan Pablo (JP) Arab, MD on the impact of alcohol use in the natural history of SLD at the MetALD Conference . Assessment of alcohol intake over time should be standardized in clinical practice. VCU VCU Stravitz-Sanyal Institute for Liver Disease Rohit Loomba Marco Arrese, MD Ramon Bataller Arun J. Sanyal


Pros and cons of current NITs in MetALD. Inflammation, excess weight, alcohol use and low specificity are the main caveats of NITs. Fantastic talk from Maja Thiele at the MetALD Conference ! #LiverTwitter Rohit Loomba Aleksander Krag EASL Education EASLnews MASLD Research Center




How to innovate in MetALD clinical trials? Rohit Loomba provided relevant considerations for security and endpoints. NITs biomarkers may play a role in early phase studies! MASLD Research Center Federica Tavaglione maral amangurbanova Veeral Ajmera Mónica Tincopa MD MSc UCSD Gastroenterology #LiverTwitter MetALD Conference


